Abstract:4387 Altered expression of Bcl-2-family proteins plays central roles in apoptosis dysregulation in cancer and leukemia, promoting malignant cell expansion and contributing to chemoresistance. In this study, we compared the toxicity and efficacy in mice of natural product (+)Gossypol and its semi-synthetic derivative (+)ApoGossypol and the purified (+) and (-) enantiomers of this compound, All of these compounds were shown to bind anti-apoptotic Bcl-2-family proteins with similar affinities, based on competitive BH3 peptide displacement assays and NMR-based chemical shift mapping experiments. Comparisons of growth inhibitory and cytotoxic activity of (+)Gossypol and (+)ApoGossypol using the NCI panel of 60 tumor cell lines, as well as cultured lymphoma cell lines and primary leukemia cells suggested that Gossypol and ApoGossypol have overlapping but non-identical cytotoxic mechanisms. Daily oral dosing studies showed that mice tolerate doses of ApoGossypol 2-4-times higher than Gossypol. Hepatotoxicity and gastrointestinal toxicity represented the major adverse activities of Gossypol, with ApoGossypol far less toxic. Efficacy was tested in transgenic mice in which Bcl-2 is over-expressed in B-cells, resembling low-grade follicular lymphoma in humans. In vitro, Bcl-2-expressing B-cells from transgenic mice were more sensitive to cytotoxicity induced by ApoGossypol than Gossypol, with LD50 values of 3-5 µM and 7.5-10 µM, respectively. In vivo, using the maximum tolerated dose of Gossypol (60 µmoles/kg) for sequential daily dosing (daily x 5 days x 3 weeks), ApoGossypol displayed superior activity to Gossypol in terms of reducing splenomegaly and reducing B-cell counts in spleens of Bcl-2 transgenic mice. At higher doses (120 µmole/kg), at which ApoGossypol but not Gossypol is tolerated, ApoGossypol showed even greater in vivo activity, reducing spleen weight by 40 ± 14% (p

The Immunosuppressive Effect of Gossypol in Mice is Mediated by Inhibition of Lymphocyte Proliferation and by Induction of Cell Apoptosis

Effects of gossypol on the in vitro proliferation and apoptosis of murine lymphocytes

Gossypol Suppresses Mouse T Lymphocytes Via Inhibition of NFκB, NFAT and AP-1 Pathways

Suppression of LPS-induced Inflammatory Responses by Gossypol in RAW 264.7 Cells and Mouse Models.

Effects of Gossypol on the Proliferation and Apoptosis of Jurkat T Cells

Inhibitory Effects of Gossypol on the Activation of Human T-lymphocytes Stimulated with Polyclonal Activators

In Vitro and in Vivo Efficacy and Toxicity Comparison Between ApoGossypol and Gossypol, Bcl-2 Antagonists

Molecular Mechanism of Gossypol-Induced Cell Growth Inhibition and Cell Death of HT-29 Human Colon Carcinoma Cells.

The Effects of (+)-Gossypol on 11 Beta-Hsd and the Concentration of Corticosterone and Dehydrocorticosterone in Mice Serum and Tissues

Differential Growth Inhibition and Induction of Apoptosis by Gossypol Between Hct116 and Hct116/Bax(-/-) Colorectal Cancer Cells

Inhibition Of Proliferation Of Prostate Cancer Cell Line, Pc-3, In Vitro And In Vivo Using (-)-Gossypol

Biological activity in the repopulating rat spermatocyte after the withdrawal of gossypol treatment. VI. Alteration in nuclear factors for interaction with histone gene promoter.

Gossypol Has Anti-Cancer Effects by Dual Targeting Mdm2 and Vegf in Human Breast Cancer

Protective Effect of Gossypol on Lipopolysaccharide-Induced Acute Lung Injury in Mice.

Gossypol Inhibits Metastasis of Lung Cell Carcinoma by Reversing Epithelial to Mesenchymal Transition and Suppressing Proteases Activity

Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cells

Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma

In Vitro Effects of the BH3 Mimetic, (−)-Gossypol, on Head and Neck Squamous Cell Carcinoma Cells

Natural Bcl-2 inhibitor (−)– gossypol induces protective autophagy via reactive oxygen species–high mobility group box 1 pathway in Burkitt lymphoma

Gossypol induces apoptosis of human pancreatic cancer cells via CHOP/endoplasmic reticulum stress signaling pathway

Prenatal Exposure to Gossypol Impairs Corticogenesis of Mouse